MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
9.14
+0.02 (0.22%)
Jan 21, 2025, 4:00 PM EST - Market closed
MiMedx Group Employees
MiMedx Group had 895 employees as of December 31, 2023. The number of employees increased by 28 or 3.23% compared to the previous year.
Employees
895
Change (1Y)
28
Growth (1Y)
3.23%
Revenue / Employee
$383,021
Profits / Employee
$91,619
Market Cap
1.34B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MDXG News
- 2 months ago - MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs - GlobeNewsWire
- 2 months ago - MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - MIMEDX Announces Third Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 3 months ago - MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 - GlobeNewsWire
- 3 months ago - MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue - GlobeNewsWire
- 4 months ago - MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall - GlobeNewsWire
- 4 months ago - EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS" - PRNewsWire
- 4 months ago - THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES' - PRNewsWire